Clinical and neurocognitive profiles of a combined clinical high risk for psychosis and clinical control sample: latent class analysis

被引:0
|
作者
Stuble, Miriam [1 ,2 ]
Schultze-Lutter, Frauke [1 ,3 ,4 ]
Kaess, Michael [1 ,5 ]
Franscini, Maurizia [6 ]
Traber-Walker, Nina [6 ]
Walger, Petra [7 ]
Schimmelmann, Benno G. [1 ]
Vogeley, Kai [8 ,9 ,10 ]
Kambeitz, Joseph [8 ,9 ]
Kindler, Jochen [1 ]
Michel, Chantal [1 ]
机构
[1] Univ Bern, Univ Hosp Child & Adolescent Psychiat & Psychother, Bern, Switzerland
[2] Univ Bern, Grad Sch Hlth Sci, Bern, Switzerland
[3] Heinrich Heine Univ, Med Fac, Dept Psychiat & Psychotherapy, Dusseldorf, Germany
[4] Airlangga Univ, Fac Psychol, Dept Psychol, Surabaya, Indonesia
[5] Heidelberg Univ, Ctr Psychosocial Med, Dept Child & Adolescent Psychiat, Heidelberg, Germany
[6] Univ Zurich, Dept Child & Adolescent Psychiat & Psychotherapy, Zurich, Switzerland
[7] Heinrich Heine Univ, Med Fac, Dept Psychiat & Psychotherapy, Dusseldorf, Germany
[8] Univ Cologne, Fac Med, Dept Psychiat & Psychotherapy, Cologne, Germany
[9] Univ Cologne, Univ Hosp Cologne, Cologne, Germany
[10] Inst Neurosci & Med, Res Ctr Julich, Cognit Neurosci INM3, Julich, Germany
来源
BJPSYCH OPEN | 2024年 / 10卷 / 06期
基金
瑞士国家科学基金会;
关键词
Psychotic symptoms; basic symptoms; neurocognition; clinical heterogeneity; early intervention; DSM-IV; GENERAL-POPULATION; BASIC SYMPTOMS; YOUNG-ADULTS; INTERVENTION; PREVALENCE; HETEROGENEITY; RELIABILITY; PREDICTION; STATE;
D O I
10.1192/bjo.2024.815
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background The clinical high-risk (CHR) state for psychosis demonstrates considerable clinical heterogeneity, presenting challenges for clinicians and researchers alike. Basic symptoms, to date, have largely been ignored in explorations of clinical profiles.Aims We examined clinical profiles by using a broader spectrum of CHR symptoms, including not only (attenuated) psychotic, but also basic symptoms.Method Patients (N = 875) of specialised early intervention centres for psychosis in Germany and Switzerland were assessed with the Schizophrenia Proneness Instruments and the Structured Interview for Psychosis-Risk Syndromes. Latent class analysis was applied to CHR symptoms to identify clinical profiles. Additionally, demographics, other symptoms, current non-psychotic DSM-IV axis I disorders and neurocognitive variables were assessed to further describe and compare the profiles.Results A three-class model was best fitting the data, whereby basic symptoms best differentiated between the profiles (eta 2 = 0.08-0.52). Class 1 had a low probability of CHR symptoms, the highest functioning and lowest other psychopathology, neurocognitive deficits and transition-to-psychosis rate. Class 2 had the highest probability of basic and (attenuated) positive symptoms (excluding hallucinations), lowest functioning, highest symptom load, most neurocognitive deficits and highest transition rate (55.1%). Class 3 was mostly characterised by attenuated hallucination, and was otherwise intermediate between the other two classes. Comorbidity rates were comparable across classes, with some class differences in diagnostic categories.Conclusions Our profiles based on basic and (attenuated) psychotic symptoms provide clinically useful entities by parsing out heterogeneity in clinical presentation. In future, they could guide class-specific intervention.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Neurocognitive function as a possible marker for remission from clinical high risk for psychosis
    Lee, Tae Young
    Shin, Ye Seul
    Shin, Na Young
    Kim, Sung Nyun
    Jang, Joon Hwan
    Kang, Do-Hyung
    Kwon, Jun Soo
    SCHIZOPHRENIA RESEARCH, 2014, 153 (1-3) : 48 - 53
  • [22] Depression symptom clusters in adolescents: A latent class analysis in a clinical sample
    Loades, Maria E.
    St Clair, Michelle C.
    Orchard, Faith
    Goodyer, Ian
    Reynolds, Shirley
    PSYCHOTHERAPY RESEARCH, 2022, 32 (07) : 860 - 873
  • [23] Latent class analysis of obsessive-compulsive symptoms in a clinical sample
    Atli, Abdullah
    Boysan, Murat
    Cetinkaya, Nuralay
    Bulut, Mahmut
    Bez, Yasin
    COMPREHENSIVE PSYCHIATRY, 2014, 55 (03) : 604 - 612
  • [24] CONVERSION STUDY OF A CHINESE SAMPLE AT CLINICAL-HIGH-RISK FOR PSYCHOSIS
    Mao, Zhen
    Bo, Qijing
    Dong, Fang
    Wang, Chuanyue
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i231 - i231
  • [25] Neurocognitive functioning for youth at clinical high risk of developing psychosis in NAPLS-2
    Seidman, Larry J.
    Shapiro, Daniel
    Stone, William S.
    Addington, Jean
    Bearden, Carrie
    Cadenhead, Kristen S.
    Cannon, Tyrone
    Cornblatt, Barbara A.
    Mathalon, Daniel H.
    Perkins, Diana O.
    Walker, Elaine F.
    Woods, Scott W.
    EARLY INTERVENTION IN PSYCHIATRY, 2014, 8 : 47 - 47
  • [26] Neurocognitive Deficits according to Norms in Adolescents with and without Clinical High Risk States of Psychosis
    Michel, Chantal
    Schnyder, Nina
    Walger, Petra
    Franscini, Maurizia
    Schimmelmann, Benno G.
    Schultze-Lutter, Frauke
    EARLY INTERVENTION IN PSYCHIATRY, 2018, 12 : 77 - 77
  • [27] Neurocognitive Deficits According to Norms in Adolescents With and Without Clinical High Risk States of Psychosis
    Michel, Chantal
    Rietschel, Liz
    Schnyder, Nina
    Walger, Petra
    Franscini, Maurizia
    Schimmelmann, Benno G.
    Schultze-Lutter, Frauke
    EARLY INTERVENTION IN PSYCHIATRY, 2016, 10 : 43 - 43
  • [28] Neurocognitive Indicators of Clinical High-Risk States for Psychosis: A Critical Review of the Evidence
    Pukrop, Ralf
    Klosterkoetter, Joachim
    NEUROTOXICITY RESEARCH, 2010, 18 (3-4) : 272 - 286
  • [29] NEUROCOGNITIVE FUNCTIONING IN CLINICAL HIGH RISK STUDIES AND IMPLICATIONS FOR COGNITIVE ENHANCEMENT IN THE PSYCHOSIS PRODROME
    Seidman, Larry J.
    Shapiro, Daniel
    Stone, William S.
    Hooker, Christine
    Woodberry, Kristen S.
    Keshavan, Matcheri S.
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S62 - S62
  • [30] Neurocognitive Indicators of Clinical High-Risk States for Psychosis: A Critical Review of the Evidence
    Ralf Pukrop
    Joachim Klosterkötter
    Neurotoxicity Research, 2010, 18 : 272 - 286